Get the Stockscreener App
1.59
3.29%
0.07
After Hours:
1.59
Cibus Inc stock is traded at $1.59, with a volume of 131.33K.
It is up +3.29% in the last 24 hours and down -28.96% over the past month.
See More
Previous Close:
$1.52
Open:
$1.5
24h Volume:
131.33K
Relative Volume:
0.83
Market Cap:
$49.61M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.0789
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
-16.04%
1M Performance:
-28.96%
6M Performance:
-49.19%
1Y Performance:
-92.09%
1-Day Range:
$1.40
$1.63
1-Week Range:
$1.40
$1.95
52-Week Range:
$1.40
$21.23
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.59 | 49.61M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.56 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.78 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
550.00 | 32.85B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.95 | 28.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
220.54 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Canaccord cuts Cibus stock target to $18, maintains buy rating - MSN
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Corient Private Wealth LLC Sells 60,000 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Charles Schwab Investment Management Inc. Sells 7,726 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline - Investing.com Australia
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline By Investing.com - Investing.com South Africa
Research Analysts Offer Predictions for Cibus Q1 Earnings - MarketBeat
HC Wainwright Reiterates Buy Rating for Cibus (NASDAQ:CBUS) - MarketBeat
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus outlines advanced gene editing initiatives with potential revenue milestones by 2026 - MSN
What is HC Wainwright’s Forecast for Cibus Q1 Earnings? - Defense World
Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright - Defense World
Cibus, Inc. (NASDAQ:CBUS) Q4 2024 Earnings Call Transcript - Insider Monkey
Cibus, Inc. Earnings Call: Strategic Progress Amid Challenges - TipRanks
Cibus (NASDAQ:CBUS) Posts Earnings Results, Misses Estimates By $0.19 EPS - MarketBeat
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - Yahoo Finance
Cibus Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus, Inc. Reports Progress in Gene Editing and Financial Results - TipRanks
Cibus: Q4 Earnings Snapshot - mySA
Earnings call transcript: Cibus Inc. Q4 2024 focuses on innovation and cost-saving - Investing.com India
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus: Q4 Earnings Snapshot -March 20, 2025 at 06:00 pm EDT - MarketScreener
Cibus Inc. (CBUS) reports earnings - Quartz
Cibus Reports Fourth Quarter Financial Results And Provides Business Update -March 20, 2025 at 04:54 pm EDT - Marketscreener.com
Cibus, Inc. SEC 10-K Report - TradingView
Cibus (CBUS) Expected to Announce Earnings on Thursday - The AM Reporter
Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward - The Manila Times
Cibus, Inc. Supports EU Legislation Advancing New Genomic Techniques for Sustainable Agriculture - Nasdaq
Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward - TradingView
Cibus director Gerhard Prante sells shares worth $6,106 - MSN
Cibus (CBUS) to Release Quarterly Earnings on Thursday - MarketBeat
Cibus (CBUS) Projected to Post Earnings on Thursday - Defense World
Cibus Achieves Another Milestone for a Durable White Mold Resistance Trait in Canola - CropLife
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call - The Manila Times
Cibus, Inc. to Report Fourth Quarter 2024 Financial Results on March 20, 2025 - Nasdaq
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close - Bluefield Daily Telegraph
Agricultural Biotech Leader Cibus Sets Q4 Earnings Date: Key Gene Editing Updates Expected - StockTitan
13,000 Shares in Cibus, Inc. (NASDAQ:CBUS) Purchased by IFP Advisors Inc - Defense World
Cibus Inc (CBUS) Shares Soar Above 1-Year High - The News Heater
Cibus’s Strategic Advancements and Leadership Transition Drive Buy Rating - TipRanks
Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola - The Manila Times
Can Cibus' Gene-Edited Canola Traits Revolutionize Crop Disease Management? - StockTitan
Cibus Announces Leadership Transition and CEO Succession Plan - Seed World
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):